No Data
SymbolStock Name
Latest PriceChg%ChgVolumeTurnoverOpenPre CloseHighLowMarket CapFloat CapSharesShs Float5D %Chg10D %Chg20D %Chg60D % Chg120D %Chg250D %Chg% Year-to-dateDiv YieldTTMTurnover RatioP/E (TTM)P/E (Static)AmplitudeIndustry
5 Biggest Winners, 5 Biggest Losers From Dow Jones Industrial Average In First Half 2024
Piper Downgrades Zimmer to Neutral, Cites Lack of Catalysts
Assessing Johnson & Johnson's Performance Against Competitors In Pharmaceuticals Industry
Cantor Fitzgerald Reiterates Overweight on Johnson & Johnson, Maintains $215 Price Target
Johnson & Johnson Analyst Ratings
Express News | U.S. Food and Drug Administration (FDA) Approves Foundationone Liquid Cdx as a Companion Diagnostic for Akeega (Niraparib and Abiraterone Acetate) for Patients With Brca-Positive Metastatic Castration-Resistant Prostate Cancer